ESC Premium Access

Clopidorel-based antiplatelet therapy is not enough for stent patency in patients undergoing femoropopliteal arterial endovascular interventions.

Congress Session

About the speaker

Doctor Kensaku Higashi

National Hospital Organization Kagoshima Medical Center, Kagoshima (Japan)
0 follower

9 more presentations in this session

Outcome of spot versus full-coverage nitinol stenting after endovascular therapy for femoropopliteal artery disease

Speaker: Doctor Y. Tomoi (Fukuoka, JP)

Thumbnail

Impact of baseline characteristics on efficacy of cilostazol for patients performing endovascular therapy for femoropopliteal lesions

Speaker: Doctor S. Hiramori (Fukuoka, JP)

Thumbnail

Long term usefulness of target lesion revascularization for asymptomatic restenosis of superficial femoral artery after endovascular therapy

Speaker: Doctor M. Utsunomiya (Tokyo, JP)

Thumbnail

Comparison of transradial vs transfemoral access for iliac, femoral, and popliteal interventions. A single-center experience

Speaker: Associate Professor Z. Ruzsa (Szeged, HU)

Thumbnail

Predictive value of vessel size for the long-term patency following self-expanding nitinol stent implantation in the superficial femoral artery

Speaker: Doctor K. Miki (Hyogo, JP)

Thumbnail

Access the full session

Poster Session 4 - Peripheral artery disease : endovascular treatment

Speakers: Doctor K. Higashi, Doctor Y. Tomoi, Doctor S. Hiramori, Doctor M. Utsunomiya, Associate Professor Z. Ruzsa...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk